ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
174 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $1.42B → $1.01B (-$408M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
174
Holding in Top 10
–
Calls
$43.9M
Puts
$18M
Top Buyers
| 1 | +$16M | |
| 2 | +$14.2M | |
| 3 | +$11.7M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$11.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.7M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$17.9M | |
| 3 | -$10.4M | |
| 4 |
Two Sigma Investments
New York
|
-$5.07M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$4.97M |